Welcome to our dedicated page for Selectis Health SEC filings (Ticker: GBCS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Selectis Health Inc. filings document a Utah public company that owns and operates healthcare facilities through subsidiaries and reports material events tied to skilled nursing facility assets. Recent 8-K disclosures cover completed dispositions of Georgia skilled nursing facilities, related purchase and sale agreements, subsidiary property interests, proceeds, escrows, debt repayment and other asset-sale terms.
The company’s SEC record also includes governance disclosures for board appointments and resignations, compensatory arrangements for directors, and changes involving executive or board roles. Capital-structure filings describe modifications to senior secured promissory notes, warrant terms and securityholder rights, while Form 12b-25 notices address annual-report timing and financial-statement preparation.
Selectis Health, Inc. reported that two wholly owned subsidiaries entered into a definitive Purchase and Sale Agreement to sell substantially all real and personal property of two skilled nursing facilities in Georgia. The facilities, Providence of Sparta Health & Rehab in Sparta and Warrenton Health and Rehabilitation in Warrenton, are being sold to entities affiliated with Journey Propco for a total purchase price of $13,175,000, subject to customary prorations, holdbacks and adjustments.
At the same time, the operating subsidiaries signed an Operations Transfer Agreement with new operator entities affiliated with the buyers, which will govern transfer of the skilled nursing operations if the property sale closes. Both agreements are subject to completion of due diligence and other customary conditions, and the company notes there can be no assurance that these transactions will be consummated.
Selectis Health, Inc. (GBCS) reported Q3 2025 results showing healthcare revenue of $10,839,954 versus $10,016,416 a year ago, driven by higher Medicaid rates in Georgia and Oklahoma. Net income was $752,365 compared to a prior-year loss, aided by $659,923 from employee retention credits and higher other income.
For the nine months, the company recorded a net loss of $211,631 versus $1,847,498 last year, with interest expense lower on reduced debt. Liquidity remains tight: cash was $417,125 and restricted cash $806,886 as of September 30, 2025, with a working capital deficit of approximately $16.3 million. Total debt, net of discount, was $31,126,545, and the company disclosed noncompliance with two loan covenants, classifying related amounts as current. Management noted substantial doubt about continuing as a going concern and outlined plans to increase occupancy and rates, control costs, and seek capital. As of November 12, 2025, common shares outstanding were 3,067,059.